Paige Leskin, July 7, 2019
Business Insider – Prostate cancer patients who take a hormone-suppressing drug may be at an increased risk for dementia and Alzheimer’s, a study has found.
The study of more than 150,000 men found a link between the degenerative diseases and a treatment drug called androgen deprivation therapy.
Researchers cautioned doctors to further consider the risks of ADT before giving it to their patients to treat prostate cancer.
There’s a 20-percent higher chance of having dementia for older men who have taken the prostate cancer treatment, according to the research study from JAMA Network … Doctor Manages Prostate Cancer Without Surgery
“Our results suggest that clinicians need to carefully weigh the long-term risks and benefits of exposure to ADT in patients with a prolonged life expectancy and stratify patients based on dementia risk prior to ADT initiation,” the researchers wrote in their study … Read more.